Risks and benefits of erythropoietin stimulating agents in cancer patients

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)38-39
    JournalHospital Pharmacy Europe
    Issue number50
    Publication statusPublished - May 2010

    Keywords

    • Cancer studies

    Cite this